当前位置:
X-MOL 学术
›
Lancet Neurol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Diagnosis and management of status epilepticus: improving the status quo
The Lancet Neurology ( IF 46.5 ) Pub Date : 2024-12-02 , DOI: 10.1016/s1474-4422(24)00430-7 Jennifer V Gettings, Fatemeh Mohammad Alizadeh Chafjiri, Archana A Patel, Simon Shorvon, Howard P Goodkin, Tobias Loddenkemper
The Lancet Neurology ( IF 46.5 ) Pub Date : 2024-12-02 , DOI: 10.1016/s1474-4422(24)00430-7 Jennifer V Gettings, Fatemeh Mohammad Alizadeh Chafjiri, Archana A Patel, Simon Shorvon, Howard P Goodkin, Tobias Loddenkemper
Status epilepticus is a common neurological emergency that is characterised by prolonged or recurrent seizures without recovery between episodes and associated with substantial morbidity and mortality. Prompt recognition and targeted therapy can reduce the risk of complications and death associated with status epilepticus, thereby improving outcomes. The most recent International League Against Epilepsy definition considers two important timepoints in status epilepticus: first, when the seizure does not self-terminate; and second, when the seizure can have long-term consequences, including neuronal injury. Recent advances in our understanding of the pathophysiology of status epilepticus indicate that changes in neurotransmission as status epilepticus progresses can increase excitatory seizure-facilitating and decrease inhibitory seizure-terminating mechanisms at a cellular level. Effective clinical management requires rapid initiation of supportive measures, assessment of the cause of the seizure, and first-line treatment with benzodiazepines. If status epilepticus continues, management should entail second-line and third-line treatment agents, supportive EEG monitoring, and admission to an intensive care unit. Future research to study early seizure detection, rescue protocols and medications, rapid treatment escalation, and integration of fundamental scientific and clinical evidence into clinical practice could shorten seizure duration and reduce associated complications. Furthermore, improved recognition, education, and treatment in patients who are at risk might help to prevent status epilepticus, particularly for patients living in low-income and middle-income countries.
中文翻译:
癫痫持续状态的诊断和管理:改善现状
癫痫持续状态是一种常见的神经系统急症,其特征是长时间或反复发作,发作间期没有恢复,并且与较高的并发症发生率和死亡率相关。及时识别和靶向治疗可以降低与癫痫持续状态相关的并发症和死亡风险,从而改善结局。国际抗癫痫联盟的最新定义考虑了癫痫持续状态的两个重要时间点:第一,癫痫发作没有自行终止;其次,当癫痫发作可能产生长期后果时,包括神经元损伤。我们对癫痫持续状态病理生理学的最新进展表明,随着癫痫持续状态的进展,神经传递的变化可以在细胞水平上增加兴奋性癫痫发作促进作用,减少抑制性癫痫发作终止机制。有效的临床管理需要迅速开始支持性治疗,评估癫痫发作的原因,并使用苯二氮卓类药物进行一线治疗。如果癫痫持续状态,管理应包括二线和三线治疗药物、支持性脑电图监测和收入重症监护病房。未来研究早期癫痫发作检测、抢救方案和药物、快速治疗升级以及将基础科学和临床证据整合到临床实践中,可以缩短癫痫发作持续时间并减少相关并发症。此外,改善对高危患者的识别、教育和治疗可能有助于预防癫痫持续状态,特别是对于生活在低收入和中等收入国家的患者。
更新日期:2024-12-02
中文翻译:
癫痫持续状态的诊断和管理:改善现状
癫痫持续状态是一种常见的神经系统急症,其特征是长时间或反复发作,发作间期没有恢复,并且与较高的并发症发生率和死亡率相关。及时识别和靶向治疗可以降低与癫痫持续状态相关的并发症和死亡风险,从而改善结局。国际抗癫痫联盟的最新定义考虑了癫痫持续状态的两个重要时间点:第一,癫痫发作没有自行终止;其次,当癫痫发作可能产生长期后果时,包括神经元损伤。我们对癫痫持续状态病理生理学的最新进展表明,随着癫痫持续状态的进展,神经传递的变化可以在细胞水平上增加兴奋性癫痫发作促进作用,减少抑制性癫痫发作终止机制。有效的临床管理需要迅速开始支持性治疗,评估癫痫发作的原因,并使用苯二氮卓类药物进行一线治疗。如果癫痫持续状态,管理应包括二线和三线治疗药物、支持性脑电图监测和收入重症监护病房。未来研究早期癫痫发作检测、抢救方案和药物、快速治疗升级以及将基础科学和临床证据整合到临床实践中,可以缩短癫痫发作持续时间并减少相关并发症。此外,改善对高危患者的识别、教育和治疗可能有助于预防癫痫持续状态,特别是对于生活在低收入和中等收入国家的患者。